[go: up one dir, main page]

ZA931133B - Process for preparing enantiomerically pure fluoronated epoxychromans - Google Patents

Process for preparing enantiomerically pure fluoronated epoxychromans

Info

Publication number
ZA931133B
ZA931133B ZA931133A ZA931133A ZA931133B ZA 931133 B ZA931133 B ZA 931133B ZA 931133 A ZA931133 A ZA 931133A ZA 931133 A ZA931133 A ZA 931133A ZA 931133 B ZA931133 B ZA 931133B
Authority
ZA
South Africa
Prior art keywords
hydrogen
epoxychromans
fluoronated
enantiomerically pure
preparing enantiomerically
Prior art date
Application number
ZA931133A
Other languages
English (en)
Inventor
David Bell
Michael Fedouloff
Gillian Turner
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA931133B publication Critical patent/ZA931133B/xx

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • B01J31/2204Organic complexes the ligands containing oxygen or sulfur as complexing atoms
    • B01J31/2208Oxygen, e.g. acetylacetonates
    • B01J31/2226Anionic ligands, i.e. the overall ligand carries at least one formal negative charge
    • B01J31/2243At least one oxygen and one nitrogen atom present as complexing atoms in an at least bidentate or bridging ligand
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/70Oxidation reactions, e.g. epoxidation, (di)hydroxylation, dehydrogenation and analogues
    • B01J2231/72Epoxidation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/02Compositional aspects of complexes used, e.g. polynuclearity
    • B01J2531/0238Complexes comprising multidentate ligands, i.e. more than 2 ionic or coordinative bonds from the central metal to the ligand, the latter having at least two donor atoms, e.g. N, O, S, P
    • B01J2531/0241Rigid ligands, e.g. extended sp2-carbon frameworks or geminal di- or trisubstitution
    • B01J2531/0252Salen ligands or analogues, e.g. derived from ethylenediamine and salicylaldehyde
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/70Complexes comprising metals of Group VII (VIIB) as the central metal
    • B01J2531/72Manganese

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA931133A 1992-02-20 1993-02-18 Process for preparing enantiomerically pure fluoronated epoxychromans ZA931133B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929203596A GB9203596D0 (en) 1992-02-20 1992-02-20 Novel process

Publications (1)

Publication Number Publication Date
ZA931133B true ZA931133B (en) 1994-06-03

Family

ID=10710733

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931133A ZA931133B (en) 1992-02-20 1993-02-18 Process for preparing enantiomerically pure fluoronated epoxychromans

Country Status (12)

Country Link
EP (1) EP0626967B1 (xx)
JP (1) JPH07504183A (xx)
KR (1) KR100245205B1 (xx)
AT (1) ATE251626T1 (xx)
AU (1) AU675420B2 (xx)
CA (1) CA2130481A1 (xx)
DE (1) DE69333240T2 (xx)
GB (1) GB9203596D0 (xx)
MX (1) MX9300895A (xx)
NZ (1) NZ249200A (xx)
WO (1) WO1993017026A1 (xx)
ZA (1) ZA931133B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0415165A (pt) 2003-10-01 2007-01-09 Adolor Corp composto heterocìclico espirocìclico, composição farmacêutica, método para ligar receptores opióides, métodos para prevenir ou tratar dor, disfunção gastrointestinal, um distúrbio do trato urogenital, um distúrbio imunomodulatório, um distúrbio inflamatório, um distúrbio de função respiratória, ansiedade, distúrbio do humor, um distúrbio relacionado a estresse, distúrbio do sistema nervoso simpático, tosse, e um distúrbio motor, método para tratar uma lesão traumática ao sistema nervoso central, métodos para prevenir ou tratar acidente vascular, arritmia cardìaca, glaucoma, e disfunção sexual, métodos para tratar uma condição selecionada do grupo consistindo de choque, edema cerebral, isquemia cerebral, déficit cerebral após cirurgia cardìaca (bypass) e enxerto, lupus eritematoso sistêmico, doença de hodgkin, doença de sjogren, epilepsia, e rejeição em transplantes de órgão e enxertos de pele, e para tratar dependência de substáncias, métodos para melhorar a sobrevivência de órgãos e células, e cardioproteção após infarto do miocárdio, métodos para reduzir a necessidade de anestesia, para produzir ou manter um estado anestésico, derivado radiomarcado de um composto, derivado isotopicamente marcado de um composto, composto e método de diagnóstico por imagem
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86798A (en) * 1987-06-23 1992-12-01 Sanofi Sa 2,2-dimethylchroman-3-ol derivatives, their preparation and pharmaceutical compositions containing them
DE68921972T2 (de) * 1988-12-13 1995-11-16 Beecham Group Plc Benzopyran und verwandte Verbindungen.
JP3487847B2 (ja) * 1990-03-21 2004-01-19 リサーチ コーポレイション テクノロジーズ,インコーポレイテッド キラル触媒及びそれにより触媒されたエポキシ化反応

Also Published As

Publication number Publication date
CA2130481A1 (en) 1993-09-02
EP0626967A1 (en) 1994-12-07
KR100245205B1 (ko) 2000-03-02
JPH07504183A (ja) 1995-05-11
DE69333240D1 (de) 2003-11-13
AU3509593A (en) 1993-09-13
NZ249200A (en) 1996-06-25
EP0626967B1 (en) 2003-10-08
KR950700306A (ko) 1995-01-16
AU675420B2 (en) 1997-02-06
MX9300895A (es) 1994-08-31
DE69333240T2 (de) 2004-08-05
ATE251626T1 (de) 2003-10-15
GB9203596D0 (en) 1992-04-08
WO1993017026A1 (en) 1993-09-02

Similar Documents

Publication Publication Date Title
HUT72192A (en) Compounds useful as sweeting agents, sweeting composition containing them and process for their preparation
EP0405864A3 (en) Phospholipase a2 inhibitor, microorganisms producing said inhibitor and processes for its production
CA2043709A1 (en) Antimigraine alkoxypyrimidine derivatives
ZA947182B (en) Process for the preparation of 3-arylbenzofuranones
AU669584B2 (en) Process for preparation of indolopyrrolocarbazole derivatives
CA2047377A1 (en) Liquid crystal racemic mixture, liquid crystal composition and liquid crystal element, process for manufacturing liquid crystal element, and uses of liquid crystal element
ZA931133B (en) Process for preparing enantiomerically pure fluoronated epoxychromans
AU6221596A (en) Method for the preparation of taxol and its derivatives
SG65685A1 (en) Process for the manufacture of alkylimidazolidone (meth)-acrylates
EP0096356A3 (en) The novel microorganism strain chromobacterium violaceum, pharmaceutically active compounds being produced by the strain, a process for preparing the compounds and the use of these compounds as medicaments
AU8606291A (en) 8-azabicyclo(3.2.1)octylalkylthiazolidinones, a process for their preparation and their use as medicaments
HU905000D0 (en) Process for producing compounds suitable for treatment of gastric ulcer
CA2129647A1 (en) Process for production of 4,4'-thiobis phenols
WO1987007603A1 (fr) COMPOSES DE beta-LACTAME ET LEUR PROCEDE DE PREPARATION
AU4983293A (en) Optically active 1-phenylpyrrolidone derivative, intermediate for producing the same, and process for producing both
AU1806197A (en) A process for the preparation of diphosphonate derivatives
AU1287892A (en) Method of inhibiting the progressive development of diabetes mellitus
EP0765866A3 (en) Preparation of optically active (S)-(-) and (R)-(+)- deoxyspergualin and novel intermediates thereof
EP0441116A3 (en) Optically active chroman derivatives and intermediates thereof, and process for manufacturing same
CA2334820A1 (en) Process for the synthesis of carbapenem intermediates, and compounds produced
JPS6450891A (en) Novel synthesis of phosphosugar derivative
MX9800041A (es) Procedimiento mejorado para sintetizar intermediarios de carbapenem.
MX9800042A (es) Metodos, composiciones, y/o articulos de limpieza/saneamiento, para superficies inanimadas no alimenticias.